QIC and EIPICO discussed the possibility of building a plant for the production of full-cycle medicines

The parties signed an agreement in which they agreed to jointly study the pharmaceutical market and cooperate in the implementation of projects in Kazakhstan.

The document was signed by Chairman of the Board of QIC Yerbolat Zholat and Chairman, Managing Director of EIPICO Ahmed Kelani.

The construction of the plant is being discussed in Almaty.

EIPICO is Egypt's largest pharmaceutical manufacturer with an assortment of more than 400 medicines. EIPICO products are the leader in the Egyptian market, accounting for 26% of the country's total pharmaceutical exports.